Skip to content
healthcare.dev

Rolvedon

NDC 82497-132, eflapegrastim-xnst, injection, solution, from Assertio Specialty Pharmaceuticals, LLC.

Product NDC
82497-132
Status
Listed
Labeler
Assertio Specialty Pharmaceuticals, LLC
Dosage form
INJECTION, SOLUTION
Route
SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
BLA
Application
BLA761148
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82497-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • EFLAPEGRASTIM13.2 mg/.6mL

Pharmacologic classes

Granulocyte Colony-Stimulating Factor [CS]; Increased Myeloid Cell Production [PE]; Leukocyte Growth Factor [EPC]

Package NDCNDC-11Package
82497-132-0182497013201.6 mL in 1 SYRINGE, GLASS (82497-132-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/2dc62c46-bb10-4a62-a459-d3eeeb6dd82f
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=82497-132

Use it

Look up 82497-132 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82497-132 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82497-132. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.